Go Pro
→ MILLIONAIRE MASTERCLASS INVITE: Altucher (From Paradigm Press) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$4.58
$10.60
$3.95
▼
$19.11
$394.85M1.637.03 million shs1.90 million shs
Nova Ltd. stock logo
NVMI
Nova
$372.10
$414.26
$248.87
▼
$615.99
$11.83B1.76466,961 shs700,426 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
0.00%+1.78%-67.03%-61.09%-67.31%
Nova Ltd. stock logo
NVMI
Nova
0.00%+6.79%-5.32%-27.68%+45.52%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$4.58
$10.60
$3.95
▼
$19.11
$394.85M1.637.03 million shs1.90 million shs
Nova Ltd. stock logo
NVMI
Nova
$372.10
$414.26
$248.87
▼
$615.99
$11.83B1.76466,961 shs700,426 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
0.00%+1.78%-67.03%-61.09%-67.31%
Nova Ltd. stock logo
NVMI
Nova
0.00%+6.79%-5.32%-27.68%+45.52%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
2.27
Hold$25.70461.14% Upside
Nova Ltd. stock logo
NVMI
Nova
2.91
Moderate Buy$514.4438.25% Upside

Current Analyst Ratings Breakdown

Latest EYPT and NVMI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/2/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$20.00 ➝ $4.00
9/1/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/18/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$17.00
8/18/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Chardan Capital logo
Chardan Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Neutral$5.00
8/18/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform ➝ Sector Perform$5.00
8/18/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral
8/17/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/17/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperform ➝ Sector Perform$5.00
8/17/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$8.00
8/17/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight ➝ Neutral
8/10/2026
Nova Ltd. stock logo
NVMI
Nova
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$595.00 ➝ $550.00
(Data available from 9/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$31.37M12.59N/AN/A$3.70 per share1.24
Nova Ltd. stock logo
NVMI
Nova
$880.58M13.43$9.67 per share38.48$44.84 per share8.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$231.96M-$3.74N/AN/AN/A-10,994.73%-135.81%-108.35%11/4/2026 (Estimated)
Nova Ltd. stock logo
NVMI
Nova
$259.22M$8.0846.0529.161.8528.84%21.41%11.95%11/5/2026 (Estimated)

Latest EYPT and NVMI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2026Q2 2026
Nova Ltd. stock logo
NVMI
Nova
$2.41$2.51+$0.10$2.20$250.33 million$254.96 million
8/5/2026Q2 2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$1.01-$1.09-$0.08-$0.2720$0.45 million$0.51 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/AN/AN/AN/AN/A
Nova Ltd. stock logo
NVMI
Nova
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/A
4.50
4.46
Nova Ltd. stock logo
NVMI
Nova
N/A
1.55
1.35

Institutional Ownership

CompanyInstitutional Ownership
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
99.41%
Nova Ltd. stock logo
NVMI
Nova
82.99%

Insider Ownership

CompanyInsider Ownership
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
5.13%
Nova Ltd. stock logo
NVMI
Nova
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
12086.21 million81.79 millionOptionable
Nova Ltd. stock logo
NVMI
Nova
1,61231.78 million31.47 millionOptionable

Recent News About These Companies

Nova (NVMI) Just Blew Past $250M In Quarterly Sales
September 7 at 5:51 AM  |  insidermonkey.comhttps://www.insidermonkey.com/blog/nova-nvmi-just-blew-past-250m-in-quarterly-sales-1829380/
Wellington Management Group LLP Decreases Stock Holdings in Nova Ltd. $NVMI
September 5 at 4:55 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-wellington-management-group-llp-decreases-stock-holdings-in-nova-ltd-nvmi-2026-09-05/
Nova gains as investors revisit strong outlook amid chip-sector rally
September 4, 2026  |  quiverquant.comQ
Raiffeisen Bank International AG Decreases Stake in Nova Ltd. $NVMI
September 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-raiffeisen-bank-international-ag-decreases-stake-in-nova-ltd-nvmi-2026-09-04/
Nova (NASDAQ:NVMI) Shares Gap Up - Should You Buy?
September 4, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31003198
Share Repurchase Plan Declared by Nova (NASDAQ:NVMI) Board of Directors
September 4, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31001660
Insider Selling: Nova (NASDAQ:NVMI) CEO Sells $513,405.00 in Stock
September 3, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-nvmi-insider-buying-and-selling-2026-09-03/
Van ECK Associates Corp Purchases 4,238 Shares of Nova Ltd. $NVMI
September 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-van-eck-associates-corp-purchases-4238-shares-of-nova-ltd-nvmi-2026-09-03/
Stock Buyback Program Initiated by Nova (NASDAQ:NVMI) Board of Directors
September 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/buyback-stock-buyback-program-initiated-by-nova-nasdaq-nvmi-board-of-directors-2026-09-02/
Insider Selling: Nova (NASDAQ:NVMI) CEO Sells 1,500 Shares
September 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-nova-nasdaq-nvmi-ceo-sells-1500-shares-2026-09-02/
Nova (NASDAQ:NVMI) Shares Gap Up - Here's Why
September 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-nova-nasdaq-nvmi-shares-gap-up-heres-why-2026-09-02/
Nova Board Authorizes Share Repurchase Program
September 2, 2026  |  rttnews.comhttps://www.rttnews.com/3687858/nova-board-authorizes-share-repurchase-program.aspx
Winners and losers of Q2: Nova (NASDAQ:NVMI) vs the rest of the semiconductor manufacturing stocks
September 2, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/winners-and-losers-of-q2-nova-nasdaqnvmi-vs-the-rest-of-the-semiconductor-manufacturing-stocks/ar-AA2blcFr
Nova Announces $200M Share Repurchase Program
September 2, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/nova-announces-200m-share-repurchase-program-302867597.html
The Manufacturers Life Insurance Company Purchases Shares of 8,854 Nova Ltd. $NVMI
September 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-the-manufacturers-life-insurance-company-purchases-shares-of-8854-nova-ltd-nvmi-2026-09-01/
AMKR vs. NVMI: Which Stock Is the Better Value Option?
August 31, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2982634/amkr-vs-nvmi-which-stock-is-the-better-value-option?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_3-2982634
Should You Invest in NVMI Stock Following Healthy Q2 Results?
August 31, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2982407/should-you-invest-in-nvmi-stock-following-healthy-q2-results?cid=cs-stocknewsapi-ft-analyst_blog|investment_ideas-2982407
11,074 Shares in Nova Ltd. $NVMI Purchased by Nissay Asset Management Corp Japan
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-11074-shares-in-nova-ltd-nvmi-purchased-by-nissay-asset-management-corp-japan-2026-08-31/
Bank of New York Mellon Corp Acquires Shares of 46,439 Nova Ltd. $NVMI
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-acquires-shares-of-46439-nova-ltd-nvmi-2026-08-31/
Nova: AI's Metrology Tollbooth Is Becoming A Multi-Engine Compounder
August 29, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4941464-nova-ais-metrology-tollbooth-is-becoming-a-multi-engine-compounder
Man Group plc Takes Position in Nova Ltd. $NVMI
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-man-group-plc-takes-position-in-nova-ltd-nvmi-2026-08-29/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Eyepoint Pharmaceuticals stock logo

Eyepoint Pharmaceuticals NASDAQ:EYPT

$4.58 0.00 (0.00%)
As of 09/4/2026 04:00 PM Eastern

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Nova stock logo

Nova NASDAQ:NVMI

$372.10 0.00 (0.00%)
As of 09/4/2026 04:00 PM Eastern

Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for dimensional, films, and materials and chemical metrology measurements for process control for various semiconductor manufacturing process steps, including lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging. The company serves various sectors of the integrated circuit manufacturing industry, including logic, foundries, and memory manufacturers, as well as process equipment manufacturers. Nova Ltd. was formerly known as Nova Measuring Instruments Ltd. and changed its name to Nova Ltd. in July 2021. Nova Ltd. was incorporated in 1993 and is headquartered in Rehovot, Israel.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas